Company Directory / Research
Public · NASDAQ:RUBYFor profitResearchCambridge, Massachusetts, United States
Rubius Therapeutics
Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.
- Founded
- 2013 13 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $445M as listed, USD
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
13 years old.
Reach
No web traffic ranking listed.
What it does
BiotechnologyHealth CarePharmaceuticalTherapeutics
What it is known for
red blood cellbiotechplatformoncologyautoimmunesciencebiotechnology: biological products (no diagnostic substances)health carebiotechnology researchbiotech industryresponsive designbiotech manufacturingpharmaceuticalsbiotechnologybiotech innovationbiotech innovation platform
What its website runs on
CloudFlare CDNCloudflare DNSCloudFlareHTTP/3Cloudflare Browser InsightsCloudflare Insights
Funding, as listed
$445M raised in total
- Rounds4
- LatestPost ipo equity, Mar 2021
- Latest amountUSD 25,000,000
- Investors1, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Rubius Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Rubius Therapeutics
- Type
- For profit
- Status
- Public · NASDAQ:RUBY
- Founded
- 2013
- Founders
- Avak Kahvejian, Jordi Mata-Fink, Noubar Afeyan
- Industry
- Research
- Categories
- Biotechnology, Health Care, Pharmaceutical, Therapeutics
Where
- City
- Cambridge
- Region
- Massachusetts
- Country
- United States
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 1-10
- Annual revenue
- $178M
Funding, as listed
- Total
- $445,000,000 USD
- Rounds
- 4
- Latest round
- Post ipo equity
- Latest round date
- Mar 2021
- Latest amount
- 25,000,000 USD
- Investors
- 1
- Lead investors
- 1
- Stock listing
- NASDAQ:RUBY
- Listing status
- public
Classification
- NAICS
- 541714, 325414
- SIC
- 2834, 2836
- Keywords
- 16 listed, shown above
- Technologies
- 6 detected, shown above
About this record
- Sources
- Crunchbase, Apollo
- Last imported
- Sept 2026
Companies like it
Research in United States.
Kemin IndustriesDes Moines · 1001-5000 peopleBBruker Cellular AnalysisEmeryville · 101-250 people
FermilabBatavia · 1001-5000 people · 96k followers
Alladapt ImmunotherapeuticsMenlo Park · 11-50 people
SeLux DiagnosticsBoston · 101-250 peopleFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.